Markes International’s Select-eV variable-energy ion-source technology has received an Honourable Mention at the Pittcon Editors’ Awards, following its introduction earlier this year.
Pittcon, The Pittsburgh Conference on Analytical Chemistry and Applied Spectroscopy, is widely regarded as one of the world’s best trade shows for innovations in analytical chemistry. It gives attendees the opportunity to observe many analytical instrument developments, all under one roof. This year, the conference attracted 16,200 attendees, including 935 exhibitors from 32 countries across 1,763 booths.
Historically, editors found it difficult to capture the very best of the new products at Pittcon. That is why, Dr Gordon Wilkinson, then managing editor of Analytical Instrument Industry Report (AIIR), came up with the idea of the Pittcon Editors’ Awards nearly a decade ago. The awards highlight the best new innovations at the show, and are judged by a panel of200 accredited media representatives.
Markes received an Honourable Mention for their Select-eV ion-source technology which was launched to the US market at Pittcon 2014 following a successful European introduction at HTC-13 in January. Select-eV breaks new ground in the field of GC–MS by enabling the ionisation energy to be varied from 70 to 10 eV at the push of a button and without loss of sensitivity. This revolutionises the identification of unknowns by enabling both reference-quality standard 70 eVspectra and repeatable ‘soft-ionisation’ spectrato be produced for each sample within a single automated sequence – boosting both productivity and data quality.
Elizabeth Woolfenden, Managing Director at Markes said, “Receiving an Honourable Mention for Select-eV is a great achievement for everyone here at Markes International. It’s fantastic to be recognised as the creators of one of the most pioneering innovations at Pittcon 2014.”
Select-eV ion-source technology can be employed in any GC–MS application, but has particular value for challenging forensic and petrochemical applications, which require users to distinguish between very similar compounds. Woolfenden adds: “Our application specialists are continuing to investigate applications of this novel technology. There are some exciting advances currently being explored, which are anticipated to generate a great deal of interest.”
Markes is part of the Mulheim-based German family business Schauenburg International Group, and also has additional technical support centres in the USA and Germany. For more information, visit www.markes.com.